← Back to Search

Predictive Analytics and Behavioral Nudges for Advanced Cancer

N/A

Waitlist Available

Led By Sandhya Mudumbi

Research Sponsored by Abramson Cancer Center of the University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 months

Awards & highlights

Study Summary

This trial seeks to improve palliative care access for cancer patients, which can improve symptom burden, quality of life, and survival.

Who is the study for?

This trial is for medical oncologists and advanced practice providers at Tennessee Oncology, treating patients with stage III or IV lung and non-colorectal GI cancers. Eligibility is determined using specific diagnosis codes, electronic health records (EHR), and manual screening.Check my eligibility

What is being tested?

The study tests if nudges in the EHR can increase palliative care use among advanced cancer patients. Practices are randomly assigned to either receive algorithm-based default referrals for palliative care or continue usual care without these prompts.See study design

What are the potential side effects?

Since this trial involves behavioral nudges rather than medications, there aren't direct physical side effects like those seen with drugs. However, changes in workflow or decision-making processes could occur.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Palliative Care Utilization in High-risk Patients

Secondary outcome measures

Palliative Care Utilization in Non-high Risk Patients

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Clinicians of patients in both arms will receive education on the availability of early palliative care and performance reports. Clinicians in the intervention arm will receive an EHR nudge with option to opt-out for palliative care referral for any eligible high-risk patient.

Group II: ControlActive Control1 Intervention

Clinicians of patients in both arms will receive education on the availability of early palliative care and performance reports. Clinicians will receive no further interventions beyond usual practice.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor

359 Previous Clinical Trials

104,477 Total Patients Enrolled

Tennessee Oncology, PLLCUNKNOWN

Abramson Cancer Center at Penn MedicineLead Sponsor

388 Previous Clinical Trials

145,102 Total Patients Enrolled

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05590962 — N/A

Cancer Research Study Groups: Control, Intervention

Cancer Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05590962 — N/A

Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05590962 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of participants for this medical research study?

"That is accurate. According to clinicaltrials.gov, this study initiated on November 9th 2022 and has been actively recruiting patients since then. 400 participants are sought out from a single medical centre."

Answered by AI

Is this experiment actively recruiting new participants?

"Affirmative, the trial is still recruiting. Clinicaltrials.gov records that it was launched on November 9th 2022 and last updated at the same time. 400 participants are needed from a single clinical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer

2022. "Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05590962.